CRANE NXT CO (CXT) Fundamental Analysis & Valuation

NYSE:CXT • US2244411052

Current stock price

43.18 USD
+0.05 (+0.12%)
Last:

This CXT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. CXT Profitability Analysis

1.1 Basic Checks

  • CXT had positive earnings in the past year.
  • CXT had a positive operating cash flow in the past year.
  • Each year in the past 5 years CXT has been profitable.
  • CXT had a positive operating cash flow in each of the past 5 years.
CXT Yearly Net Income VS EBIT VS OCF VS FCFCXT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

  • CXT has a better Return On Assets (4.66%) than 70.16% of its industry peers.
  • Looking at the Return On Equity, with a value of 11.58%, CXT is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
  • CXT's Return On Invested Capital of 7.93% is fine compared to the rest of the industry. CXT outperforms 75.00% of its industry peers.
  • CXT had an Average Return On Invested Capital over the past 3 years of 11.93%. This is above the industry average of 8.36%.
Industry RankSector Rank
ROA 4.66%
ROE 11.58%
ROIC 7.93%
ROA(3y)7.07%
ROA(5y)6.96%
ROE(3y)16.13%
ROE(5y)16.85%
ROIC(3y)11.93%
ROIC(5y)11.12%
CXT Yearly ROA, ROE, ROICCXT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • CXT has a better Profit Margin (8.76%) than 79.84% of its industry peers.
  • In the last couple of years the Profit Margin of CXT has grown nicely.
  • The Operating Margin of CXT (15.91%) is better than 90.32% of its industry peers.
  • In the last couple of years the Operating Margin of CXT has grown nicely.
  • CXT has a better Gross Margin (42.48%) than 72.58% of its industry peers.
  • CXT's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 15.91%
PM (TTM) 8.76%
GM 42.48%
OM growth 3Y-6.41%
OM growth 5Y12.78%
PM growth 3Y-16.95%
PM growth 5Y5.97%
GM growth 3Y-3.13%
GM growth 5Y3.98%
CXT Yearly Profit, Operating, Gross MarginsCXT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. CXT Health Analysis

2.1 Basic Checks

  • CXT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for CXT has been increased compared to 1 year ago.
  • Compared to 5 years ago, CXT has less shares outstanding
  • CXT has a worse debt/assets ratio than last year.
CXT Yearly Shares OutstandingCXT Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
CXT Yearly Total Debt VS Total AssetsCXT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

  • An Altman-Z score of 1.89 indicates that CXT is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • CXT's Altman-Z score of 1.89 is on the low side compared to the rest of the industry. CXT is outperformed by 63.71% of its industry peers.
  • CXT has a debt to FCF ratio of 5.75. This is a neutral value as CXT would need 5.75 years to pay back of all of its debts.
  • The Debt to FCF ratio of CXT (5.75) is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.91 indicates that CXT is somewhat dependend on debt financing.
  • CXT has a worse Debt to Equity ratio (0.91) than 87.10% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF 5.75
Altman-Z 1.89
ROIC/WACC0.85
WACC9.31%
CXT Yearly LT Debt VS Equity VS FCFCXT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.3 Liquidity

  • CXT has a Current Ratio of 1.50. This is a normal value and indicates that CXT is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.50, CXT is doing worse than 76.61% of the companies in the same industry.
  • CXT has a Quick Ratio of 1.20. This is a normal value and indicates that CXT is financially healthy and should not expect problems in meeting its short term obligations.
  • CXT's Quick ratio of 1.20 is on the low side compared to the rest of the industry. CXT is outperformed by 69.35% of its industry peers.
Industry RankSector Rank
Current Ratio 1.5
Quick Ratio 1.2
CXT Yearly Current Assets VS Current LiabilitesCXT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. CXT Growth Analysis

3.1 Past

  • The earnings per share for CXT have decreased by -4.92% in the last year.
  • CXT shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.12% yearly.
  • The Revenue has grown by 11.43% in the past year. This is quite good.
  • The Revenue has been decreasing by -9.71% on average over the past years.
EPS 1Y (TTM)-4.92%
EPS 3Y-19.21%
EPS 5Y1.12%
EPS Q2Q%5.83%
Revenue 1Y (TTM)11.43%
Revenue growth 3Y7.33%
Revenue growth 5Y-9.71%
Sales Q2Q%19.49%

3.2 Future

  • The Earnings Per Share is expected to grow by 8.32% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 5.29% on average over the next years.
EPS Next Y6.3%
EPS Next 2Y8.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.38%
Revenue Next 2Y5.29%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CXT Yearly Revenue VS EstimatesCXT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
CXT Yearly EPS VS EstimatesCXT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

8

4. CXT Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 10.64 indicates a reasonable valuation of CXT.
  • Compared to the rest of the industry, the Price/Earnings ratio of CXT indicates a rather cheap valuation: CXT is cheaper than 92.74% of the companies listed in the same industry.
  • CXT is valuated cheaply when we compare the Price/Earnings ratio to 25.50, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 10.00, the valuation of CXT can be described as very reasonable.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CXT indicates a rather cheap valuation: CXT is cheaper than 90.32% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of CXT to the average of the S&P500 Index (22.67), we can say CXT is valued rather cheaply.
Industry RankSector Rank
PE 10.64
Fwd PE 10
CXT Price Earnings VS Forward Price EarningsCXT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • 88.71% of the companies in the same industry are more expensive than CXT, based on the Enterprise Value to EBITDA ratio.
  • CXT's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CXT is cheaper than 88.71% of the companies in the same industry.
Industry RankSector Rank
P/FCF 12.51
EV/EBITDA 8.78
CXT Per share dataCXT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

  • CXT's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The excellent profitability rating of CXT may justify a higher PE ratio.
PEG (NY)1.69
PEG (5Y)9.49
EPS Next 2Y8.32%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. CXT Dividend Analysis

5.1 Amount

  • CXT has a Yearly Dividend Yield of 1.73%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 0.46, CXT pays a better dividend. On top of this CXT pays more dividend than 93.55% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, CXT has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.73%

5.2 History

  • On average, the dividend of CXT grows each year by 6.42%, which is quite nice.
  • CXT has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)6.42%
Div Incr Years0
Div Non Decr Years0
CXT Yearly Dividends per shareCXT Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • CXT pays out 26.88% of its income as dividend. This is a sustainable payout ratio.
  • CXT's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP26.88%
EPS Next 2Y8.32%
EPS Next 3YN/A
CXT Yearly Income VS Free CF VS DividendCXT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
CXT Dividend Payout.CXT Dividend Payout, showing the Payout Ratio.CXT Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CXT Fundamentals: All Metrics, Ratios and Statistics

CRANE NXT CO

NYSE:CXT (3/25/2026, 12:15:08 PM)

43.18

+0.05 (+0.12%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)02-11
Earnings (Next)05-05
Inst Owners113.86%
Inst Owner ChangeN/A
Ins Owners0.27%
Ins Owner Change4.91%
Market Cap2.48B
Revenue(TTM)1.66B
Net Income(TTM)145.10M
Analysts81.82
Price Target91.36 (111.58%)
Short Float %13.81%
Short Ratio9.48
Dividend
Industry RankSector Rank
Dividend Yield 1.73%
Yearly Dividend0.68
Dividend Growth(5Y)6.42%
DP26.88%
Div Incr Years0
Div Non Decr Years0
Ex-Date02-27
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.06%
Min EPS beat(2)0.03%
Max EPS beat(2)0.1%
EPS beat(4)4
Avg EPS beat(4)1.37%
Min EPS beat(4)0.03%
Max EPS beat(4)3.95%
EPS beat(8)6
Avg EPS beat(8)0.66%
EPS beat(12)10
Avg EPS beat(12)5.62%
EPS beat(16)13
Avg EPS beat(16)5.54%
Revenue beat(2)2
Avg Revenue beat(2)3.34%
Min Revenue beat(2)1.89%
Max Revenue beat(2)4.78%
Revenue beat(4)3
Avg Revenue beat(4)1.73%
Min Revenue beat(4)-2.45%
Max Revenue beat(4)4.78%
Revenue beat(8)4
Avg Revenue beat(8)0.72%
Revenue beat(12)7
Avg Revenue beat(12)1.19%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.09%
PT rev (3m)-3.98%
EPS NQ rev (1m)-15.7%
EPS NQ rev (3m)-35.37%
EPS NY rev (1m)-5.05%
EPS NY rev (3m)-8.31%
Revenue NQ rev (1m)-2.07%
Revenue NQ rev (3m)-4.8%
Revenue NY rev (1m)-0.57%
Revenue NY rev (3m)-0.51%
Valuation
Industry RankSector Rank
PE 10.64
Fwd PE 10
P/S 1.5
P/FCF 12.51
P/OCF 10.27
P/B 1.98
P/tB N/A
EV/EBITDA 8.78
EPS(TTM)4.06
EY9.4%
EPS(NY)4.32
Fwd EY10%
FCF(TTM)3.45
FCFY8%
OCF(TTM)4.2
OCFY9.74%
SpS28.84
BVpS21.81
TBVpS-8.15
PEG (NY)1.69
PEG (5Y)9.49
Graham Number44.64
Profitability
Industry RankSector Rank
ROA 4.66%
ROE 11.58%
ROCE 10.34%
ROIC 7.93%
ROICexc 8.69%
ROICexgc 29.25%
OM 15.91%
PM (TTM) 8.76%
GM 42.48%
FCFM 11.97%
ROA(3y)7.07%
ROA(5y)6.96%
ROE(3y)16.13%
ROE(5y)16.85%
ROIC(3y)11.93%
ROIC(5y)11.12%
ROICexc(3y)13.26%
ROICexc(5y)12.51%
ROICexgc(3y)48.49%
ROICexgc(5y)45.78%
ROCE(3y)15.59%
ROCE(5y)14.95%
ROICexgc growth 3Y-18.71%
ROICexgc growth 5Y16.5%
ROICexc growth 3Y-13.43%
ROICexc growth 5Y8.62%
OM growth 3Y-6.41%
OM growth 5Y12.78%
PM growth 3Y-16.95%
PM growth 5Y5.97%
GM growth 3Y-3.13%
GM growth 5Y3.98%
F-Score4
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF 5.75
Debt/EBITDA 3.08
Cap/Depr 40.53%
Cap/Sales 2.61%
Interest Coverage 4.74
Cash Conversion 65.25%
Profit Quality 136.66%
Current Ratio 1.5
Quick Ratio 1.2
Altman-Z 1.89
F-Score4
WACC9.31%
ROIC/WACC0.85
Cap/Depr(3y)44.3%
Cap/Depr(5y)36.54%
Cap/Sales(3y)2.63%
Cap/Sales(5y)2.17%
Profit Quality(3y)119.51%
Profit Quality(5y)128.53%
High Growth Momentum
Growth
EPS 1Y (TTM)-4.92%
EPS 3Y-19.21%
EPS 5Y1.12%
EPS Q2Q%5.83%
EPS Next Y6.3%
EPS Next 2Y8.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)11.43%
Revenue growth 3Y7.33%
Revenue growth 5Y-9.71%
Sales Q2Q%19.49%
Revenue Next Year6.38%
Revenue Next 2Y5.29%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-14.09%
EBIT growth 3Y0.45%
EBIT growth 5Y1.82%
EBIT Next Year18.85%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y17.55%
FCF growth 3Y-11.36%
FCF growth 5Y-6.44%
OCF growth 1Y12.8%
OCF growth 3Y-7.59%
OCF growth 5Y-4.84%

CRANE NXT CO / CXT Fundamental Analysis FAQ

What is the fundamental rating for CXT stock?

ChartMill assigns a fundamental rating of 6 / 10 to CXT.


Can you provide the valuation status for CRANE NXT CO?

ChartMill assigns a valuation rating of 8 / 10 to CRANE NXT CO (CXT). This can be considered as Undervalued.


What is the profitability of CXT stock?

CRANE NXT CO (CXT) has a profitability rating of 8 / 10.


How financially healthy is CRANE NXT CO?

The financial health rating of CRANE NXT CO (CXT) is 3 / 10.


Is the dividend of CRANE NXT CO sustainable?

The dividend rating of CRANE NXT CO (CXT) is 6 / 10 and the dividend payout ratio is 26.88%.